Pandit, 2015, Demographic and clinical features of neuromyelitis optica: a review, Mult Scler, 21, 845, 10.1177/1352458515572406
Davoudi, 2016, Immunology of neuromyelitis optica during pregnancy, Neurol Neuroimmunol Neuroinflamm, 3, e288, 10.1212/NXI.0000000000000288
Dean, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729
Bourre, 2012, Neuromyelitis optica and pregnancy, Neurology, 78, 875, 10.1212/WNL.0b013e31824c466f
Shang, 2011, Neuromyelitis optica during pregnancy, Int J Gynecol Obstet, 115, 66, 10.1016/j.ijgo.2011.05.016
Saadoun, 2010, Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice, Brain, 133, 349, 10.1093/brain/awp309
Pauklin, 2009, Estrogen directly activates AID transcription and function, J Exp Med, 206, 99, 10.1084/jem.20080521
Chen, 2012, Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer, J Proteomics, 75, 2824, 10.1016/j.jprot.2012.02.001
Goulabchand, 2014, Impact of autoantibody glycosylation in autoimmune diseases, Autoimmun Rev, 13, 742, 10.1016/j.autrev.2014.02.005
Kim, 2012, Influence of pregnancy on neuromyelitis optica spectrum disorder, Neurology, 78, 1264, 10.1212/WNL.0b013e318250d812
Jurewicz, 2015, Relapse of neuromyelitis optica during pregnancy-treatment options and literature review, Clin Neurol Neurosurg, 130, 159, 10.1016/j.clineuro.2014.12.023
Ringelstein, 2013, Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum, Mult Scler, 19, 1544, 10.1177/1352458513498125
Shang, 2011, Neuromyelitis optica during pregnancy, Int J Gynaecol Obstet, 115, 66, 10.1016/j.ijgo.2011.05.016
Nour, 2016, Pregnancy outcomes in aquaporin-4 – positive neuromyelitis optica spectrum disorder, Neurology, 86, 79, 10.1212/WNL.0000000000002208
Mariotto, 2014, HCV-related central and peripheral nervous system demyelinating disorders, Inflamm Allergy Drug Targets, 13, 299, 10.2174/1871528113666140908113841
Kitada, 2012, Acute combined central and peripheral demyelination showing antiaquaporin 4 antibody positivity, Intern Med, 51, 2443, 10.2169/internalmedicine.51.7590
Sellner, 2010, EFNS guidelines on diagnosis and management of neuromyelitis optica, Eur J Neurol, 17, 1019, 10.1111/j.1468-1331.2010.03066.x
Wong, 2015, Rituximab in neuromyelitis optica: a review of literature, World J Neurol, 5, 39, 10.5316/wjn.v5.i1.39
Shosha, 2017, Neuromyelitis optica spectrum disorders and pregnancy: interactions and management, Mult Scler, 23, 1808, 10.1177/1352458517740215